Unicycive Therapeutics stock holds at USD 4.80

Published on 09/20/2026 at 16:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Unicycive Therapeutics stock closed at USD 4.80 on September 18, 2026, with a market value of USD 133.68 million. MarketBeat shows a 52-week range from USD 3.71 to USD 8.74.

UNCY, US90467V1098, Illustration mit AI erstellt.

Unicycive Therapeutics stock (US90467V1098) closed at USD 4.80 on September 18, 2026, giving the company a market capitalization of USD 133.68 million and a 52-week range of USD 3.71 to USD 8.74. The latest MarketBeat snapshot also shows volume of 1.11 million shares and a consensus price target of USD 18.75.

Analysts still point higher

According to MarketBeat on September 19, 2026, Unicycive Therapeutics has a consensus rating of Moderate Buy, based on 5 buy ratings, 1 hold rating and 1 sell rating. The same snapshot puts the average target at USD 18.75, or about 290.6 percent above the USD 4.80 closing price.

That gap matters because the stock is still trading far below the analysts' average target even after the latest close. For investors, the spread between USD 4.80 and USD 18.75 is the main valuation anchor in the current data.

Trading range stays wide

MarketBeat's September 19, 2026 data also show a 52-week range from USD 3.71 to USD 8.74, with the last close sitting closer to the lower half of that band than the top. Volume of 1.11 million shares was above the reported average volume of 769,798 shares.

The combination of a USD 4.80 close and trading volume above the average suggests active repositioning around the name. The market is still pricing UNCY well below the USD 8.74 high from the same 52-week window.

Closing price and setup

Unicycive Therapeutics stock finished at USD 4.80 on September 18, 2026, on Nasdaq. The latest market snapshot gives the shares a USD 133.68 million market capitalization and a USD 3.71 to USD 8.74 52-week range.